Eudragit(®) FS Microparticles Containing Bacteriophages, Prepared by Spray-Drying for Oral Administration

Phage therapy is recognized to be a promising alternative to fight antibiotic-resistant infections. In the quest for oral dosage forms containing bacteriophages, the utilization of colonic-release Eudragit(®) derivatives has shown potential in shielding bacteriophages from the challenges encountered...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabare, Emilie, Dauchot, Tiffany, Cochez, Christel, Glonti, Tea, Antoine, Céline, Laforêt, Fanny, Pirnay, Jean-Paul, Delcenserie, Véronique, Thiry, Damien, Goole, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305712/
https://www.ncbi.nlm.nih.gov/pubmed/37376051
http://dx.doi.org/10.3390/pharmaceutics15061602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305712/
https://www.ncbi.nlm.nih.gov/pubmed/37376051
http://dx.doi.org/10.3390/pharmaceutics15061602

Ejemplares similares